Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Clinical trial NCT05616793 · RECRUITING
Trial details
- NCT number
- NCT05616793
- Sponsor
- Opus Genetics, Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2028-06-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.